Clinical trials
Completed Prostatic Hyperplasia trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Allergan | 2 |
| CMX Research | 2 |
| Eli Lilly and Company | 2 |
| GlaxoSmithKline | 2 |
| Sophiris Bio Corp | 2 |
| AEterna Zentaris | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Boston Scientific Corporation | 1 |
| British Columbia Cancer Agency | 1 |
| Dean Elterman | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Hyperplasia | 29 |
| Lower Urinary Tract Symptoms | 4 |
| Prostatic Neoplasms | 4 |
| Urinary Bladder, Overactive | 2 |
| Erectile Dysfunction | 1 |
| Urinary Retention | 1 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.